Buy ADB-FUBINACA new online
ADB-FUBINACA is a designer drug identified in synthetic cannabis blends in Japan in 2013. The (S) enantiomer of ADB-FUBINACA is claimed in Pfizer patent WO 2009/106982 and has been reported to be a potent agonist of the CB1 receptor and CB2 receptor with an EC50 value of 1.2 nM and 3.5 nM respectively. ADB-FUBINACA features a carboxamide group at the 3-indazole position, like SDB-001 and STS-135. ADB-FUBINACA appears to be the product of rational drug design, since it differs from AB-FUBINACA only by the replacement of the isopropyl group with a tert-butyl group.
An analogue of ADB-FUBINACA, ADSB-FUB-187, containing a more functionalized carboxamide substituent was recently reported.
Active substances in ADB-FUBINACA
Contains one gramm of min 98%+ pure ADB-FUBINACA per order unit.
Dosage of ADB-FUBINACA
There is no recomended dose since ADB-FUBINACA is not for human consumption but is sold only as a research chemical for research purpose.
Effects of ADB-FUBINACA :
The clinical effects of most new designer drugs like ADB-FUBINACA can be described as either hallucinogenic, stimulant, or opioid-like. They may also have a combination of these effects due to designer side-chain substitutions.
Side effects of ADB-FUBINACA
Like other designer drugs the use of ADB-FUBINACA can cause strong side effects; the substance is not clinically tested nor licensed in any way as a product for consumption! Therefore ADB-FUBINACA is NOT FOR HUMAN CONSUMPTION but for SCIENTIFICAL RESEARCH ONLY!
How to store ADB-FUBINACA
Keep ADB-FUBINACA below 30 degrees Celsius. Store ADB-FUBINACA in the original package, protect from direct sunlight and moisture.